Statement Of Cash Flows [Abstract]

Medistim - Filing #2546555

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for depreciation expense
23 657 NOK
23 288 NOK
Income taxes paid, classified as operating activities
25 699 NOK
19 167 NOK
Cash flows from (used in) investing activities [abstract]
Payments for development project expenditure
13 327 NOK
11 851 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.